Cardiff Oncology (CRDF) COO Ajay Aggarwal submits initial insider ownership

Rhea-AI Filing Summary

Cardiff Oncology, Inc. Chief Operating Officer Ajay Aggarwal has filed an initial statement of beneficial ownership on Form 3. The filing reports no buy, sell, or other equity transactions and shows no derivative positions, serving as a baseline disclosure of his insider status.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Aggarwal Ajay

(Last) (First) (Middle)

11055 FLINTKOTE AVENUE

(Street)

SAN DIEGO CALIFORNIA 92121

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
04/27/2026

3. Issuer Name and Ticker or Trading Symbol
Cardiff Oncology, Inc. [ CRDF ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Ajay Aggawral	04/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Cardiff Oncology (CRDF) Form 3 for Ajay Aggarwal show?

The Form 3 for Cardiff Oncology’s COO Ajay Aggarwal reports his initial beneficial ownership position as an insider. It shows no reported purchases, sales, or derivative transactions, establishing a baseline disclosure of his holdings at the time of becoming a reporting person.

Did Cardiff Oncology (CRDF) COO Ajay Aggarwal buy or sell shares in this Form 3?

No, the Form 3 for Cardiff Oncology COO Ajay Aggarwal reports no buy or sell transactions. All transaction counts and share figures are zero, indicating only an initial ownership statement rather than any trading activity in company securities.

Are there any stock options or derivatives reported for CRDF COO Ajay Aggarwal?

The filing shows no derivative positions for Cardiff Oncology COO Ajay Aggarwal. The derivative transaction count is zero and the derivative summary is empty, indicating no options, warrants, or similar instruments are reported in this initial ownership statement.

Why is a Form 3 filed for Cardiff Oncology (CRDF) COO Ajay Aggarwal?

Form 3 is filed when someone becomes an insider, such as a key officer, at Cardiff Oncology. For COO Ajay Aggarwal, it formally discloses his beneficial ownership status at the start of his reporting obligations, even though no transactions are reported in this filing.